Liver Transplant
New liver transplant study findings reported from S. Beckebaum and co-authors
Published in Hospital Law Weekly, October 15th, 2009
According to a study from Essen, Germany, "Long-term complications of calcineurin inhibitor (CNI)-based immunosuppression after liver transplantation (LT) have a marked impact on patient morbidity and mortality. In this prospective study, LT patients with renal dysfunction. were randomized (2:1) to either receive mycophenolate mofetit (MMF) followed by stepwise reduction of CNI with defined minimal CNI trough levels (MMF group) or to continue their maintenance CNI dose (control group)."
"In the MMF group (n = 60), renal function assessed by serum creatinine improved >10% in 67% of patients, was stable in 32%, and deteriorated >10% in 2% after 12 months compared...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hospital Law Weekly
Source: Hospital Law Weekly (2009-10-15)
More Articles from Hospital Law Weekly
- M2SYS Technology
M2SYS Donated Revolutionary Fingerprint System to Bwindi Community Hospital to Identify Patients - Medicare and Medicaid
Indiana and Alabama Hospitals to Pay U.S. Over $8 Million to Settle False Claims Act Allegations - Medicare and Medicaid
New Jersey Hospital to Pay $8.3 Million for Alleged Kickbacks and Causing Submission of False Claims to Medicare - Medicare and Medicaid
Proposed Medicare Changes Will Increase Costs to Government, Decrease Options for Patients - Medicare and Medicaid
Six Hospitals in Indiana and Alabama Pay $8.3 Million to Settle Whistleblower Lawsuit for Medicare Fraud - Military Officers Association of America
MOAA Decries 21% TRICARE Inpatient Copay Hike - More from this issue of Hospital Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
